NRG1 and head and neck squamous cell carcinoma: Interestingly, KTN3379 did not result in anti-tumor activity in a NRG1-positive model (CTG-0776), suggesting that NRG1 positivity alone may not be sufficient to predict KTN3379 activity in HNSCC.